RxDoctor Payments Data

Omar El Abd, MD

Interventional Pain Medicine · Wellesley, MANPI 1831189364

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Orthofix Medical, Inc.. That places this record below the midpoint for interventional pain medicine clinicians in MA, where the typical reported total is $4,278.

$63in general payments, 2019–2025

Across 1 payment — averaging $62.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$63

What the payments were for

  • Food & beverage$63100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Orthofix Medical, Inc.1$63

How this compares

$63 in reported general payments places this provider in the 5th percentile of 22 interventional pain medicine providers in Massachusetts.

See all interventional pain medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$671,066
Medicare patients
765
Services billed
27,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin194$1,416
Tizanidine Hcl71$328
Zonisamide35$249
Oxycodone Hcl29$111
Meloxicam29$48
Diazepam22$18

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Wellesley

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →